EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Construction and validation of a novel cuproptosis-mitochondrion prognostic model related with tumor immunity in osteosarcoma

Jinyan Feng, Jinwu Wang, Yao Xu, Feng Lu, Jin Zhang, Xiuxin Han, Chao Zhang, Guowen Wang iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0288180 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Jinyan Feng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Ti…. Hauptthemen laut MEDLINE: Osteosarcoma, Bone Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The purpose of this study was to develop a new prognostic model for osteosarcoma based on cuproptosis-mitochondrion genes. Materials and methods The data of osteosarcoma were obtained from TARGET database. By using Cox regression and LASSO regression analysis, a novel risk score was constructed based on cuproptosis-mitochondrion genes. Kaplan-Meier, ROC curve and independent prognostic analyses were performed to validate the risk score in GSE21257 dataset. Then, a predictive nomogram was constructed and further validated by calibration plot, C-index and ROC curve. Based on the risk score, all patients were divided into high-risk and low-risk group. GO and KEGG enrichment, immune correlation and drug sensitivity analyses were performed between groups. Real-time quantitative PCR verified the expression of cuproptosis-mitochondrion prognostic model genes in osteosarcoma. And we explored the function of FDX1 in osteosarcoma by western blotting, CCK8, colony formation assay, wound healing assay and transwell assays.

Results

A total of six cuproptosis-mitochondrion genes (FDX1, COX11, MFN2, TOMM20, NDUFB9 and ATP6V1E1) were identified. A novel risk score and associated prognostic nomogram were constructed with high clinical application value. Strong differences in function enrichment and tumor immune microenvironment were shown between groups. Besides, the correlation of cuproptosis-mitochondrion genes and drug sensitivity were revealed to search for potential therapeutic target. The expression of FDX1, COX11, MFN2, TOMM20 and NDUFB9 at mRNA level was elevated in osteosarcoma cells compared with normal osteoblast hFOB1.19. The mRNA expression level of ATP6V1E1 was decreased in osteosarcoma. Compared with hFOB1.19, western blotting revealed that the expression of FDX1 was significantly elevated in osteosarcoma cells. Functional experiments indicated that FDX1 mainly promoted the migration of osteosarcoma rather than proliferation.

Conclusions

We developed a novel prognostic model of osteosarcoma based on cuproptosis-mitochondrion genes, which provided great guidance in survival prediction and individualized treatment decision making for patients with osteosarcoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaBone NeoplasmsHumansPrognosisMitochondriaGenes, MitochondrialMembrane Transport ProteinsApoptosisCopperTumor Microenvironment

Substanzen

Membrane Transport ProteinsCopper

Autor:innen und Institutionen

  • Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
  • Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
  • Tianjin's Clinical Research Center for Cancer, Tianjin, China.

ORCID-Profile: Guowen Wang

Förderung

  • the National Natural Science Foundation of China

Zitieren

APA

Feng, J., Wang, J., Xu, Y., Lu, F., Zhang, J., Han, X., Zhang, C., & Wang, G. (2023). Construction and validation of a novel cuproptosis-mitochondrion prognostic model related with tumor immunity in osteosarcoma. PLOS ONE. https://doi.org/10.1371/journal.pone.0288180

Vancouver

Feng J, Wang J, Xu Y, Lu F, Zhang J, Han X, et al. Construction and validation of a novel cuproptosis-mitochondrion prognostic model related with tumor immunity in osteosarcoma. PLOS ONE. 2023. doi:10.1371/journal.pone.0288180

BibTeX
@article{Feng2023,
  author = {Feng, Jinyan and Wang, Jinwu and Xu, Yao and Lu, Feng and Zhang, Jin and Han, Xiuxin and Zhang, Chao and Wang, Guowen},
  title = {Construction and validation of a novel cuproptosis-mitochondrion prognostic model related with tumor immunity in osteosarcoma},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0288180}
}
Kostenlos starten →